Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 764906, 13 pages
http://dx.doi.org/10.1155/2015/764906
Research Article

Inhibitory Effects of Cytosolic Ca2+ Concentration by Ginsenoside Ro Are Dependent on Phosphorylation of IP3RI and Dephosphorylation of ERK in Human Platelets

1Department of Biomedical Laboratory Science, College of Biomedical Science and Engineering, Inje University, 197 Inje-ro, Gimhae, Gyungnam 621-749, Republic of Korea
2Department of Biomedical Laboratory Science, Korea Nazarene University, 48 Wolbong-ro, Seobuk gu, Cheonan, Chungnam 331-778, Republic of Korea

Received 12 May 2015; Accepted 27 July 2015

Academic Editor: Hongcai Shang

Copyright © 2015 Hyuk-Woo Kwon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. M. Heemskerk and S. O. Sage, “Calcium signalling in platelets and other cells,” Platelets, vol. 5, no. 6, pp. 295–316, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. T. J. Rink and S. O. Sage, “Calcium signaling in human platelets,” Annual Review of Physiology, vol. 52, pp. 431–449, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. S. O. Sage, “The Wellcome Prize Lecture. Calcium entry mechanisms in human platelets,” Experimental Physiology, vol. 82, no. 5, pp. 807–823, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Berridge and R. F. Irvine, “Inositol trisphosphate, a novel second messenger in cellular signal transduction,” Nature, vol. 312, no. 5992, pp. 315–321, 1984. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Cattaneo, “The P2 receptors and congenital platelet function defects,” Seminars in Thrombosis and Hemostasis, vol. 31, no. 2, pp. 168–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. G. F. Guidetti, P. Lova, B. Bernardi et al., “The Gi-coupled P2Y12 receptor regulates diacylglycerol-mediated signaling in human platelets,” The Journal of Biological Chemistry, vol. 283, no. 43, pp. 28795–28805, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. K. Jennings, “Role of platelets in atherothrombosis,” The American Journal of Cardiology, vol. 103, no. 3, pp. 4A–10A, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Nishikawa, T. Tanaka, and H. Hidaka, “Ca2+-calmodulin-dependent phosphorylation and platelet secretion,” Nature, vol. 287, no. 5785, pp. 863–865, 1980. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kaibuchi, K. Sano, M. Hoshijima, Y. Takai, and Y. Nishizuka, “Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation,” Cell Calcium, vol. 3, no. 4-5, pp. 323–335, 1982. View at Publisher · View at Google Scholar · View at Scopus
  10. U. R. Schwarz, U. Walter, and M. Eigenthaler, “Taming platelets with cyclic nucleotides,” Biochemical Pharmacology, vol. 62, no. 9, pp. 1153–1161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Cavallini, M. Coassin, A. Borean, and A. Alexandre, “Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation,” The Journal of Biological Chemistry, vol. 271, no. 10, pp. 5545–5551, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. T. M. Quinton and W. L. Dean, “Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits Ca2+ release from platelet membranes,” Biochemical and Biophysical Research Communications, vol. 184, no. 2, pp. 893–899, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Rosado and S. O. Sage, “Phosphoinositides are required for store-mediated calcium entry in human platelets,” The Journal of Biological Chemistry, vol. 275, no. 13, pp. 9110–9113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Rosado and S. O. Sage, “Coupling between inositol 1,4,5-trisphosphate receptors and human transient receptor potential channel 1 when intracellular Ca2+ stores are depleted,” Biochemical Journal, vol. 350, no. 3, pp. 631–635, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Rosado and S. O. Sage, “The actin cytoskeleton in store-mediated calcium entry,” The Journal of Physiology, vol. 526, no. 2, pp. 221–229, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. J. A. Rosado and S. O. Sage, “A role for the actin cytoskeleton in the initiation and maintenance of store-mediated calcium entry in human platelets,” Trends in Cardiovascular Medicine, vol. 10, no. 8, pp. 327–332, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Rosado and S. O. Sage, “Role of the ERK pathway in the activation of store-mediated calcium entry in human platelets,” The Journal of Biological Chemistry, vol. 276, no. 19, pp. 15659–15665, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Rosado and S. O. Sage, “The ERK cascade, a new pathway involved in the activation of store-mediated calcium entry in human platelets,” Trends in Cardiovascular Medicine, vol. 12, no. 5, pp. 229–234, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Sanada, N. Kondo, J. Shoji, O. Tanaka, and S. Shibata, “Studies on the saponins of ginseng. I. Structures of ginsenoside-Ro, -Rb1, -Rb2, -Rc and -Rd,” Chemical & Pharmaceutical Bulletin, vol. 22, no. 2, pp. 421–428, 1974. View at Google Scholar
  20. K.-T. Choi, “Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng CA Meyer,” Acta Pharmacologica Sinica, vol. 29, no. 9, pp. 1109–1118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Ernst, “Panax ginseng: an overview of the clinical evidence,” Journal of Ginseng Research, vol. 34, no. 4, pp. 259–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-K. Kim and J. H. Park, “Trends in ginseng research in 2010,” Journal of Ginseng Research, vol. 35, no. 4, pp. 389–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. I.-M. Chung, J. W. Lim, W.-B. Pyun, and H. Kim, “Korean red ginseng improves vascular stiffness in patients with coronary artery disease,” Journal of Ginseng Research, vol. 34, no. 3, pp. 212–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. J. Wee, Y. S. Kim, J. S. Kyung et al., “Identification of anticoagulant components in Korean red ginseng,” Journal of Ginseng Research, vol. 34, no. 4, pp. 355–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. H. Jung, K. Y. Park, J. H. Jeon et al., “Red ginseng saponin fraction A isolated from Korean red ginseng by ultrafiltration on the porcine coronary artery,” Journal of Ginseng Research, vol. 35, no. 3, pp. 325–330, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-Y. Hwang, D. J. Son, I.-W. Kim et al., “Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits,” Phytotherapy Research, vol. 22, no. 6, pp. 778–783, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. D.-H. Lee, H.-J. Cho, H.-Y. Kang, M.-H. Rhee, and H.-J. Park, “Total saponin from Korean Red Ginseng inhibits thromboxane A2 production associated microsomal enzyme activity in platelets,” Journal of Ginseng Research, vol. 36, no. 1, pp. 40–46, 2012. View at Publisher · View at Google Scholar
  28. C.-M. Teng, S.-C. Kuo, F.-N. Ko et al., “Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 990, no. 3, pp. 315–320, 1989. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Grynkiewicz, M. Poenie, and R. Y. Tsien, “A new generation of Ca2+ indicators with greatly improved fluorescence properties,” The Journal of Biological Chemistry, vol. 260, no. 6, pp. 3440–3450, 1985. View at Google Scholar · View at Scopus
  30. A. J. Marcus, D. Zucker-Franklin, L. B. Safier, and H. L. Ullman, “Studies on human platelet granules and membranes,” Journal of Clinical Investigation, vol. 45, no. 1, pp. 14–28, 1966. View at Publisher · View at Google Scholar · View at Scopus
  31. D. J. Goode and H. Y. Meltzer, “Cytotoxic effects of imipramine on platelets,” Biochemical Pharmacology, vol. 23, no. 18, pp. 2629–2635, 1974. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Fujiwara, H. Banno, Y. Shinkai, C. Yamamoto, T. Kaji, and M. Satoh, “Protective effect of pretreatment with cilostazol on cytotoxicity of cadmium and arsenite in cultured vascular endothelial cells,” The Journal of Toxicological Sciences, vol. 36, no. 2, pp. 155–161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Holmsen and H. J. Day, “The selectivity of the thrombin-induced platelet release reaction: subcellular localization of released and retained constituents,” The Journal of Laboratory and Clinical Medicine, vol. 75, no. 5, pp. 840–855, 1970. View at Google Scholar · View at Scopus
  34. J. F. Mustard and M. A. Packham, “Factors influencing platelet function: adhesion, release, and aggregation,” Pharmacological Reviews, vol. 22, no. 2, pp. 97–187, 1970. View at Google Scholar · View at Scopus
  35. I. F. Charo, R. D. Feinman, and T. C. Detwiler, “Inhibition of platelet secretion by an antagonist of intracellular calcium,” Biochemical and Biophysical Research Communications, vol. 72, no. 4, pp. 1462–1467, 1976. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Broos, H. B. Feys, S. F. De Meyer, K. Vanhoorelbeke, and H. Deckmyn, “Platelets at work in primary hemostasis,” Blood Reviews, vol. 25, no. 4, pp. 155–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Zarbock, R. K. Polanowska-Grabowska, and K. Ley, “Platelet-neutrophil-interactions: linking hemostasis and inflammation,” Blood Reviews, vol. 21, no. 2, pp. 99–111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Davì and C. Patrono, “Mechanisms of disease: platelet activation and atherothrombosis,” The New England Journal of Medicine, vol. 357, no. 24, pp. 2482–2494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. K. S. Authi, B. J. Evenden, and N. Crawford, “Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets,” Biochemical Journal, vol. 233, no. 3, pp. 707–718, 1986. View at Google Scholar · View at Scopus
  40. C.-M. Teng, S.-C. Kuo, F.-N. Ko et al., “Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng,” Biochimica et Biophysica Acta—General Subjects, vol. 990, no. 3, pp. 315–320, 1989. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Castro-Malaspina, E. M. Rabellino, A. Yen, R. L. Nachman, and M. A. Moore, “Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts,” Blood, vol. 57, no. 4, pp. 781–787, 1981. View at Google Scholar · View at Scopus
  42. J. Holash, P. C. Maisonpierre, D. Compton et al., “Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF,” Science, vol. 284, no. 5422, pp. 1994–1998, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Nagai, T. Suzuki, K. Aizawa, T. Shindo, and I. Manabe, “Significance of the transcription factor KLF5 in cardiovascular remodeling,” Journal of Thrombosis and Haemostasis, vol. 3, no. 8, pp. 1569–1576, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Schwartz and M. A. Reidy, “Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension,” Human Pathology, vol. 18, no. 3, pp. 240–247, 1987. View at Publisher · View at Google Scholar · View at Scopus
  45. M. A. Packham and J. F. Mustard, “The role of platelets in the development and complications of atherosclerosis,” Seminars in Hematology, vol. 23, no. 1, pp. 8–26, 1986. View at Google Scholar · View at Scopus
  46. S. M. Schwartz and R. Ross, “Cellular proliferation in atherosclerosis and hypertension,” Progress in Cardiovascular Diseases, vol. 26, no. 5, pp. 355–372, 1984. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Seppä, G. Grotendorst, S. Seppä, E. Schiffmann, and G. R. Martin, “Platelet-derived growth factor is chemotactic for fibroblasts,” The Journal of Cell Biology, vol. 92, no. 2, pp. 584–588, 1982. View at Publisher · View at Google Scholar · View at Scopus
  48. D. R. Phillips, P. B. Conley, U. Sinha, and P. Andre, “Therapeutic approaches in arterial thrombosis,” Journal of Thrombosis and Haemostasis, vol. 3, no. 8, pp. 1577–1589, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Matsuda, K.-I. Samukawa, and M. Kubo, “Anti-inflammatory activity of ginsenoside Ro,” Planta Medica, vol. 56, no. 1, pp. 19–23, 1990. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Kim, M. Oh, B. Kim et al., “Upregulation of heme oxygenase-1 by ginsenoside Ro attenuates lipopolysaccharide-induced inflammation in macrophage cells,” Journal of Ginseng Research, 2015. View at Publisher · View at Google Scholar
  51. J. S. Park and J. Y. Cho, “Anti-inflammatory effects of ginsenosides from Panax ginseng and their structural analogs,” African Journal of Biotechnology, vol. 8, no. 16, pp. 3682–3690, 2009. View at Google Scholar · View at Scopus
  52. H. Matsuda, K. Namba, S. Fukuda, T. Tani, and M. Kubo, “Pharmacological study on Panax ginseng C. A. Meyer. III. Effects of red Ginseng on experimental disseminated intravascular coagulation. (2). Effects of ginsenosides on blood coagulative and fibrinolytic systems,” Chemical and Pharmaceutical Bulletin, vol. 34, no. 3, pp. 1153–1157, 1986. View at Publisher · View at Google Scholar
  53. H. Matsuda, K. Namba, S. Fukuda, T. Tani, and M. Kubo, “Pharmacological study on Panax ginseng C.A. Meyer IV. Effects of red ginseng on experimental disseminated intravascular coagulation. (3). Effect of ginsenoside-Ro on the blood coagulative and fibrinolytic system,” Chemical & Pharmaceutical Bulletin, vol. 34, no. 5, pp. 2100–2104, 1986. View at Publisher · View at Google Scholar · View at Scopus